PNPhan Nguyen

Phan Nguyen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Phan Nguyen has a total of 171 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Study Protocol of the Endobronchial VAlves for Pneumothorax to Reduce Admission Time ( EVAPoRATe ) Pilot Multicentre Randomised Clinical Trial

    by Nai‐Chien Huan, Niranjan Ananda Setty, Ai Ling Tan, Dhaval Thakkar, Taha Huseini, Elaine Yap, Jonathan Williamson, Phan Nguyen, Paul Lilburn, Matthew Salamonsen, et al.

    Background: Pneumothorax with persistent air leak (PAL) is a debilitating condition. Patients with PAL often require prolonged chest drainage, with associated complications, such as, hospital‐acquired infections, thromboembolism, and deconditioning. Endobronchial valves (EBVs) are an approved bronchoscopic treatment for PAL and may allow earlier chest tube removal and hospital discharge. Current evidence supporting the use of EBV is limited to case series and uncontrolled studies. EBVs are usually used as a last resort when other treatments failed. Whether early referral for EBV placement is feasible and can reduce hospital length of stay in patients with pneumothorax and PAL has not been tested in a randomised controlled trial (RCT). Methods: EVAPoRATe is a prospective, open‐labelled, pilot, multi‐centre RCT. Forty patients with pneumothorax of any cause and PAL who are unsuitable for or unwilling to undergo surgical management will be randomised 1:1 to the Early EBV Referral arm or the Standard Care arm. Patients in the Early EBV Referral arm will be assessed by an interventional clinician for EBV placement at the earliest feasible time from Day 5 of pneumothorax. Patients allocated to the Standard Care arm will receive conventional management by the attending team; EBV is allowed if clinically appropriate when air leak persists after 12 days. Participants will be followed for 6 months after discharge. Discussion: The primary outcome is the feasibility of the trial protocol, assessed by recruitment rate, adherence to the intervention arm, and retention at follow‐up. Secondary outcomes include total hospital length of stay, PAL‐related length of stay, interventions for PAL and EBV complications, time to air leak cessation, time to chest drain removal, pneumothorax recurrence, adverse events and serious adverse events, removal of EBVs, performance status, and mortality. This pilot feasibility study will assess whether a future full‐scale RCT of EBV for PAL is practical and will provide data to guide protocol refinement and sample size calculation. Trial Registration: Australian New Zealand Clinical Trials Registry: ACTRN12625000360415; https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=388086&isReview=true

  • Open Access

    Autophagy Is Suppressed in Peripheral Blood Mononuclear Cells During Chronic Obstructive Pulmonary Disease

    by James M. Cooper, Shiye Chen, Susan E. Lester, Julia Kim, Jason Gummow, Thomas Crowhurst, Emily Lawton, Arash Badiei, Phan T. Nguyen, Paul N. Reynolds, et al.

    Assessing autophagy may offer insights into the pathogenesis of chronic obstructive pulmonary disease (COPD). However, measuring the dynamic aspect of autophagy is challenging, and sample manipulation can cause signal fluctuations that deviate from physiological conditions. We applied an organotypic method to quantify autophagy in COPD, where it frequently demonstrates disease-related dysregulation. Blood from control and COPD participants was treated with or without chloroquine. Microtubule-associated protein 1 light chain 3B II (LC3B-II) abundance was quantified in peripheral blood mononuclear cells (PBMCs), and findings were validated by transmission electron microscopy. Our observations show that while basal LC3B-II abundance was similar between groups (p = 0.60), autophagic flux was significantly lower in the COPD cohort, suggesting disruption in the regulatory factors that direct autophagosome clearance (p = 0.004). This was supported by less frequent observations of autophagy-related vacuoles in the cytosol of COPD-derived PBMCs. Our findings indicate that the suppression of autophagy can be detected in the blood of individuals with COPD, which warrants further investigation into its contribution to extrapulmonary disease processes.

  • Open Access

    Lymph Node Sampling Patterns and Completeness of Staging During Systematic Mediastinal Lymph Node Staging in Patients with Locally Advanced Non-Small-Cell Lung Cancer: A Post Hoc Analysis from the SEISMIC Study

    by Kanishka Rangamuwa, Ashleigh Witt, Joseph M. Curran, Gargi Kothari, Neil Wallace, Nicholas Hardcastle, Shaun Yo, Farzad Bashirdazeh, Phan Nguyen, Barton R. Jennings, et al.

    Introduction: Systematic endoscopic mediastinal lymph node (LN) staging in early stage non-small-cell lung cancer (NSCLC) is widely recommended for optimal pre-operative staging due to imperfect accuracy of PET/CT. The SEISMIC study utilized synoptic reporting of findings during systematic endoscopic staging to inform radiotherapy planning in patients with locally advanced NSCLC and established a significant rate of discordance between PET-identified extent of disease and observed findings following EBUS. International guidelines recommend systematic LN staging in patients with clinical nodal stage (cN) 1–3 disease as a quality indicator, though performance metrics for quality assessment of systematic endoscopic mediastinal staging in NSCLC have not been described. Methods: A post hoc analysis of 155 participants with locally advanced NSCLC recruited to the SEISMIC study who underwent systematic endoscopic mediastinal staging, with sampling of all LN ≥ 6 mm, prior to planning of radical or high-dose palliative radiation, was completed. Synoptic procedural reports and pre-procedure PET imaging were examined to determine the number of LN sampled, as well as the number of radiologically normal LN ( 6 mm at higher station than the highest LN identified by PET not sampled endoscopically, confirming a high rate of complete mediastinal assessment. Conclusions: Quality of systematic staging in the SEISMIC study was high. Synoptic reporting supports high quality systematic endoscopic mediastinal LN staging in NSCLC and enables performance monitoring of systematic EBUS staging. Novel quality metrics are proposed for quality assessment, and consistent use of these may encourage more extensive LN sampling.


  • Open Access

    Palliative care interventions for thoracic cancer: a systematic review and meta-analysis identifying the core elements

    by Anne M. Walker, Donald R. Sullivan, Anne E. Holland, Phan Nguyen, Sarah Yeo, Amy Pascoe, Lorena Romero, Natasha Smallwood

    Introduction: Despite increasing trials examining palliative care for people with thoracic cancer, implementation remains limited. Understanding the core elements of palliative care interventions is critical to improving design, scalability, and accessibility globally. This review aimed to determine the core elements and efficacy of palliative care interventions in thoracic cancer. Methods: Five medical databases were searched from January 1987 to January 2025. Randomised controlled trials (RCTs) and nonrandomised studies of palliative care interventions in thoracic cancer addressing at least two National Consensus Project domains were eligible. Meta-analyses of RCTs were performed using a random-effects model. Results: 34 palliative care interventions (n=6490, mean± sd age 65±10 years, 41% women) were identified. Interventions were categorised as comprehensive palliative care interventions (n=18), nonpharmacological symptom interventions (n=12) and psychosocial-educational interventions (n=4). Comprehensive interventions were significantly longer (21.7 weeks) than nonpharmacological symptom (4.8 weeks) and psychosocial-educational interventions (8.7 weeks; p<0.01), addressed more components (mean components: 8, 3, 4, respectively; p<0.01), were often provided by specialist palliative care clinicians (83%, 16%, 0%; p<0.01), and included interprofessional teams (61%, 8%, 0%; p<0.01). Comprehensive palliative care interventions improved quality of life (standardised mean difference (SMD) 0.25, 95% CI 0.11–0.38), survival (hazard ratio 0.76, 95% CI 0.62–0.94), overall symptoms (SMD 0.20, 95% CI 0.02–0.38) and depression (SMD 0.28, 95% CI 0.07–0.5). Nonpharmacological symptom interventions improved breathlessness (SMD 0.29, 95% CI 0.15–0.43) and depression (SMD 0.17, 95% CI 0.02–0.31). Psychosocial-educational interventions did not affect quality of life or mood. Conclusions: Comprehensive palliative care interventions improved quality of life, survival and symptoms among people with thoracic cancers. Nonpharmacological symptom interventions improved breathlessness and depression.

  • Open Access

    Recurrent Cryptogenic Ulcerative Tracheobronchitis 6 Years After Lung Transplantation: Case Report

    by Samuel Brookes, Paroma Sarkar, Thomas Crowhurst, Phan Nguyen, Aeneas Yeo, Kate D. Lynch, Helen Whitford, Mark Holmes, Chien-Li Holmes-Liew

    Background: Tracheobronchitis is an uncommon pattern of airway disease and is typically caused by infection, inhalation injury, infiltrative disorders and more rarely, systemic autoimmune disease. Rarer again is the development of bronchial webbing following tracheobronchitis. The underlying aetiology is usually identified through biopsy, culture or a detailed clinical history. We present a case of cryptogenic ulcerative tracheobronchitis with bronchial webbing being successfully managed by bilateral lung transplantation that has, however, been complicated by recurrence. Case Presentation: In 2019, Crowhurst et al. detailed the case of a patient who presented with dyspnoea and haemoptysis. Bronchoscopy revealed ulcerative tracheobronchitis and he subsequently formed recurrent web‐like stenoses of the central bronchi, leading to rapidly progressive type 2 respiratory failure; he received bilateral sequential lung transplantation for definitive management. At the time of transplant, the presumed diagnosis was an inhalation injury that occurred while travelling in Vietnam, or exposure to the organophosphate pesticide Malathion several days prior. The explanted lung histology revealed ulcerating bronchitis with intense histiocytic infiltrates, bronchial luminal fibrosis and obstruction with scant, poorly formed granulomas. The patient thrived with stable lung function and had minimal complications initially post‐transplantation. However, 6 years after lung transplantation and without re‐exposure, the patient re‐developed ulcerative tracheobronchitis, which shared similar histopathologic features to airway involvement of Crohn’s disease. Gastrointestinal or other organ system involvement of Crohn’s disease was not established despite extensive investigations. A decision for phenotypic treatment with the TNF‐ α inhibitor, infliximab, was made with subsequent rapid improvement in the tracheobronchitis. Conclusion: This is the first case documented in the literature of ulcerative tracheobronchitis followed by intense bronchial web‐like stenoses caused by an unspecified autoimmune disease, treated by bilateral lung transplantation. The disease recurred after 6 years and responded to phenotypic management with the TNF‐ α inhibitor, infliximab. The patient will require careful monitoring given the risk of augmented immunosuppression and unknown disease trajectory.

  • Open Access

    The value of V/Q SPECT/CT lobar quantitation for pre-treatment assessment of lung malignancy

    by Michael V. Brown, Phan Nguyen, Ben Crouch, Arash Badiei, Joseph Inauen, Hien Le, Craig Jurisevic, Chong Ghee Chew

    Predicting post-treatment lung function is critical in selecting curative-intent therapies like surgery or stereotactic ablative body radiotherapy (SABR) for early-stage lung cancer. Current guidelines estimate predicted post-operative (PPO) function using lobar volume, ignoring regional variation in ventilation and perfusion, especially in diseased lungs. We aimed to assess the feasibility of ventilation/perfusion single photon emission computed tomography/computed tomography (V/Q SPECT/CT) lobar quantification for improved prediction of post-treatment lung function. We developed a novel index—Ventilation-Perfusion Capacity Differential Index (VQCDI)—using in-house software that quantifies lobar ventilation, perfusion and volume, reflecting each lobe’s contribution to lung function. The software enables manual annotation of surgical margins and radiation fields, allowing regional quantification. Patients undergoing lobectomy, sub-lobar resection or SABR were prospectively enrolled. VQCDI and CT-based volumetric predictions (Vol%) of PPO forced expiratory volume in 1 second (FEV1), diffusing capacity of the lungs for carbon monoxide (DLCO) and haemoglobin-corrected DLCO (DLCOc) were compared to 6-month post-treatment measurements using Pearson correlation, intraclass coefficients (ICC) and Bland-Altman analysis. Fifty-three of 60 sequentially enrolled participants completed post-treatment lung function. VQCDI predicted post-treatment FEV1 in surgical participants with a strong correlation (R=0.920, ICC =0.908, mean difference: −0.096 L) outperforming Vol%. For DLCO and DLCOc, VQCDI also showed strong correlation in surgical participants (R=0.899, ICC =0.874, and R=0.921, ICC =0.899). Performance remained high across participants undergoing lobectomy and sub-lobar resection and in smokers and those with emphysema. VQCDI may also be useful in the quantification of lung function changes in acute radiation pneumonitis post-SABR using 100%, 75%, 50% and 25% radiation dose isocontour zones. VQCDI is a feasible tool that appears to accurately predict post-treatment lung function, with novel capability in sub-lobar resection and post-SABR evaluation. Further multicentre studies with longer follow-up would be beneficial.


  • Open Access

    Contemporary Concise Review 2024: New Techniques in Interventional Pulmonology

    by Phan Nguyen, Pallav L. Shah

    SUMMARY OF KEY POINTS: Navigational bronchoscopy and cone beam computed tomography (CBCT) guided bronchoscopy show comparable yields to percutaneous transthoracic needle biopsy of lung nodules. Robotic assisted bronchoscopy (RAB) with advanced imaging (CBCT or digital tomosynthesis) improves diagnostic yield further. Endobronchial ultrasound (EBUS) guided nodal cryobiopsy shows promise in certain clinical conditions. The thin EBUS convex probe (EBUS‐CP) bronchoscope is on the horizon and has the potential to be the answer for the middle third. Guidelines and expert recommendations are sometimes needed where larger trial evidence may be lacking. Artificial intelligence is still finding its place in practice but shows promise for education and training.


  • Open Access

    Visualising ventilation changes following endobronchial valve placement with x-ray velocimetry functional lung imaging

    by Ronan Smith, Charlotte Thomas, Phan Nguyen, Arash Badiei, Nina Eikelis, Kristopher Nilsen, Piraveen Pirakalathanan, David Parsons, Martin Donnelley

    Objective. Endobronchial valves (EBVs) are a minimally invasive treatment for emphysema. After bronchoscopic placement the valves reduce the flow of air into targeted areas of the lung, causing collapse, and allowing the remainder of the lung to function more effectively. This pilot study aims to demonstrate the capability and potential of a new imaging modality—x-ray velocimetry (XV)—for detecting these changes to lung function. Approach. XV is a novel method that uses x-ray images taken during a breath to track lung motion, producing 3D maps of local ventilation. Healthy sheep received a computed tomography (CT) scan and underwent XV imaging before and after EBVs were placed in the lung. Sheep were imaged again when the EBVs were removed after 14 days. Main results. XV enabled visualisation and quantification of a reduction of airflow to the areas downstream of the EBVs, both in areas where collapse was and was not visible in CT. Changes to ventilation were also clearly visible in the remainder of the lungs. Significance. This preclinical pilot study has shown XV is capable of detecting changes to ventilation caused by EBV placement, paving the way towards use in patients.


  • Radial EBUS

    by Arash Badiei, Phan Nguyen

    The solitary pulmonary nodule (SPN) has long been a diagnostic challenge for respiratory physicians. Radial probe endobronchial ultrasound (RP-EBUS) has been one of the major advances in improving the diagnostic yield of bronchoscopic biopsy of SPNs. In this chapter, we cover the indications for RP-EBUS, including adjunctive methods, such as sampling tools, navigational bronchoscopy, and the more recent technological advances.

  • Open Access

    Management of complex adult airway pathology through a multidisciplinary approach: An 8‐year case series

    by Marie Nguyen, Sahil Goel, Liem Tran, Maryam Khan, Hubertus Jersmann, Phan Nguyen, Suren Krishnan, John‐Charles Hodge, Andrew Foreman